Outpatient and Specialty Care Stocks Post Strong Q2 Results

Yahoo Finance··US·Read original
2▲4 ▼1Impact / 5
Summary · why it matters

Outpatient and specialty care stocks tracked by the publication reported strong second-quarter results, with revenues beating analysts' consensus estimates by 2.6% and next quarter's revenue guidance coming in 3.3% above expectations. U.S. Physical Therapy reported revenues of $214.1 million, up 8.5% year on year, exceeding expectations by 1.9% but missing EPS estimates significantly. LifeStance Health Group delivered the biggest analyst estimate beat, fastest revenue growth, and highest full-year guidance raise in the group, with revenues of $435.4 million, up 26.1% year on year. DaVita reported revenues of $3.55 billion, up 5.2% year on year, but missed full-year EPS guidance estimates and delivered the weakest performance against analyst estimates among its peers. Surgery Partners reported revenues of $848.9 million, up 2.7% year on year, beating expectations by 2.2%, while agilon health reported revenues of $1.49 billion, up 7.2% year on year, surpassing expectations by 2.8% and delivering the highest guidance raise in the group.

Impact on assets 5

Health Care▲ · 3 stocks
Aging Population± Mixed · 2 stocks
agilon health Inc
AGL
▲ PositiveCapitalrelevance

Revenues beat expectations and highest guidance raise in group

© 2026 MarketIVNews